Moderna is establishing manufacturing footholds in far-flung outposts including Australia, Kenya, Canada and the U.K. Now, the company is setting up a plant closer to home in Massachusetts. The ...
British-based researchers are hoping to reduce the costs of mRNA production by expanding the range of manufacturing techniques. A team has created and are testing a huge library of RNA-polymerases, ...
RIO RANCHO, N.M.--(BUSINESS WIRE)--Nature’s Toolbox (NTx), a life sciences company developing next-generation platforms for RNA and protein manufacturing, today launched NTx Services. This new service ...
TriLink BioTechnologies, a unit of Maravai LifeSciences, said it plans to expand its mRNA manufacturing operations to meet growing demand from late-stage drug developers. The new 32,000-square-foot ...
The "mRNA Therapeutics Contract Development & Manufacturing Organization - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for mRNA ...
A 3-year research program, funded by the FDA, aims to design the first continuous mRNA-manufacturing platform. Faculty at the Massachusetts Institute of Technology (MIT; MA, USA) will be leading a ...
Dublin, Dec. 09, 2025 (GLOBE NEWSWIRE) -- The "mRNA Synthesis and Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Product, Application Area, Therapeutic Area and Key ...
The importance of in vitro transcription as a component of the mRNA therapeutic manufacturing workflow has grown significantly in recent years. The in-process raw materials for synthetic mRNA ...
MAINZ, GERMANY, and SINGAPORE, November 14, 2022 — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific Pte. Ltd. had ...
Sensible Biotechnologies aims to build a cell-based platform for cost-efficient and scalable manufacturing of high-quality mRNA. Proceeds will be used to optimize and scale Sensible's mRNA ...
MAINZ, Germany, October 26, 2021 — BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Company plans to initiate the construction of the first state-of-the-art manufacturing site for ...
CAMBRIDGE, MA -- A three-year research program led by faculty at MIT aims to design the world’s first fully integrated, continuous mRNA manufacturing platform, in an $82 million effort funded by the U ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback